NEW YORK (GenomeWeb News) – The Blue Genomics Consortium Chile is providing $17 million in funding to perform genomics-based research into why some Atlantic salmon and trout seem resistant to Caligus and Salmon Rickettsial Syndrome (SRS).

Chilean government organization Corporation for Production Development (CORFO) last year approved $7.9 million to the project, which includes four partners, AquaGen Norway, Chile AquaGen, German vaccine production firm Vaxxinova, and Norwegian company BioBank.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.